Dismetabolic disorders in military personnel from the perspective of fruit-containing beverages consumption
https://doi.org/10.51922/2074-5044.2026.2.129
Abstract
The primary objective of the study was to assess the amount of fructose consumed by military personnel aged 19–47 years, including both sweetened soft drinks and refined sugar. The average daily intake of added fructose from sweetened beverages was 8 g, while the average daily intake from refined sugar was 12 g, compared to the acceptable daily intake of 15–20 g. Excessive amounts of added fructose were identified in the general military rations. Increased fructose consumption was associated with increased BMI, hyperuricemia, elevated blood pressure, dyslipidemia, and steatohepatitis. The results were compared with current literature. A health bulletin, «The Effect of Fructose on the Human Body,» was designed.
About the Authors
T. A. NekhaichikBelarus
Minsk
S. N. Goduyko
Belarus
Minsk
A. A. Bova
Belarus
Minsk
R. F. Ermolkevich
Belarus
Minsk
D. M. Kuntsevich
Belarus
Minsk
References
1. Profilaktika neinfekcionnyh zabolevanij i bor’ba s nimi v Belarusi: Argumenty v pol’zu investirovaniya [Tekst] / Vsemirnaya organizaciya zdravoohraneniya. – Kopengagen : Evropejskoe regional’noe byuro VOZ, 2018. – 1 elektron. opt. disk (CD-ROM). – Rezhim dostupa: https://apps.who.int/iris/handle/10665/343255.
2. Global Burden of Diseases, 2019 [Elektronnyj resurs]. – Rezhim dostupa: https://vizhub.healthdata.org/gbd-results// (data obrashcheniya: 04.11.2025).
3. Epidemiologiya pitaniya: Rossiya 2018–2023 [Tekst] / pod red. V. A. Tutel’yana, D. B. Nikityuka. – M. : TD DeLi, 2024. – 270 s.
4. Busnatu, S. S. The Role of Fructose as a Cardiovascular Risk Factor: An Update [Tekst] / S. S. Busnatu, T. Salmen, M. A. Pana et al. // Metabolites. – 2022. – Vol. 12, № 1. – P. 67. – DOI: 10.3390/metabo12010067.
5. Miller, A. Dietary fructose and the metabolic syndrome [Tekst] / A. Miller, K. Adeli // Curr. Opin. Gastroenterol. – 2008. – Vol. 24. – P. 204–209.
6. Li, Z. Fructose metabolism and its roles in metabolic diseases, inflammatory diseases, and cancer [Tekst] / Z. Li, X. Fan, F. Gao et al. // Mol Biomed. – 2025. – Vol. 6. – Art. 43. – DOI: 10.1186/s43556-025-00287-2.
7. Abdelmalek, M. F. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease [Tekst] / M. F. Abdelmalek, A. Suzuki, C. Guy et al. // Hepatology. – 2010. – Vol. 51, № 6. – P. 1961–1971. – DOI: 10.1002/hep.23535.
8. Liu, C. Association between Serum Total Osteocalcin Level and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis [Tekst] / C. Liu, J. Wo, Q. Zhao et al. // Horm Metab Res. – 2015. – Vol. 47, № 11. – P. 813–819. – DOI: 10.1055/s-0035-1564134.
9. Tappy, L. Metabolic effects of fructose and the world-wide increase in obesity [Tekst] / L. Tappy, K. A. Lê // Physiol Rev. – 2010. – Vol. 90, № 1. – P. 23–46. – DOI: 10.1152/physrev.00019.2009.
10. Rippe, J. M. Fructose-containing sugars and cardiovascular disease [Tekst] / J. M. Rippe, T. J. Angelopoulos // Adv Nutr. – 2015. – Vol. 6, № 4. – P. 430–439. – DOI: 10.3945/an.114.008177.
11. Righetti, S. Effects of Maltodextrin-Fructose Supplementation on Inflammatory Biomarkers and Lipidomic Profile Following Endurance Running: A Randomized Placebo-Controlled Cross-Over Trial [Tekst] / S. Righetti, A. Medoro, F. Graziano et al. // Nutrients. – 2024. – Vol. 16, № 18. – DOI: 10.3390/nu16183077.
12. Febbraio, M. A. «Sweet death»: Fructose as a metabolic toxin that targets the gut-liver axis [Tekst] / M. A. Febbraio, M. Karin // Cell Metab. – 2021. – Vol. 33, № 12. – P. 2316–2328. – DOI: 10.1016/j.cmet.2021.09.004.
13. Lodge, M. Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease [Tekst] / M. Lodge, R. Dykes, A. Kennedy // Biomolecules. – 2024. – Vol. 14, № 7. – DOI: 10.3390/biom14070845.
14. Taskinen, M. R. Dietary Fructose and the Metabolic Syndrome [Tekst] / M. R. Taskinen, C. J. Packard, J. Borén // Nutrients. – 2019. – Vol. 11, № 9. – DOI: 10.3390/nu11091987.
15. Mirtschink, P. Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease [Tekst] / P. Mirtschink, C. Jang, Z. Arany, W. Krek // Eur Heart J. – 2018. – Vol. 39, № 26. – P. 2497–2505. – DOI: 10.1093/eurheartj/ehx518.
16. Jung, S. Dietary Fructose and Fructose-Induced Pathologies [Tekst] / S. Jung, H. Bae, W. S. Song, C. Jang // Annu Rev Nutr. – 2022. – Vol. 42. – P. 45–66. – DOI: 10.1146/annurev-nutr-062220-025831.
17. Jones, N. Fructose reprogrammes glutamine-dependent oxidative metabolism to support LPS-induced inflammation [Tekst] / N. Jones, J. Blagih, F. Zani et al. // Nat Commun. – 2021. – Vol. 12, № 1. – Art. 1209. – DOI: 10.1038/s41467-021-21461-4.
18. Goncalves, M. D. High-fructose corn syrup enhances intestinal tumor growth in mice [Tekst] / M. D. Goncalves, C. Lu, J. Tutnauer et al. // Science. – 2019. – Vol. 363, № 6433. – P. 1345–1349. – DOI: 10.1126/science.aat8515.
19. Wang Y. High-Fructose Diet Increases Inflammatory Cytokines and Alters Gut Microbiota Composition in Rats [Tekst] / Y. Wang, W. Qi, G. Song et al. // Mediators Inflamm. – 2020. – Vol. 2020. – Art. 6672636. – DOI: 10.1155/2020/6672636.
20. Jaiswal, N. High fructose-induced metabolic changes enhance inflammation in human dendritic cells [Tekst] / N. Jaiswal, S. Agrawal, A. Agrawal // Clin Exp Immunol. – 2019. – Vol. 197, № 2. – P. 237–249. – DOI: 10.1111/cei.13299.
21. Sheptulina, A. F. Fruktoza i ee vliyanie na obmen veshchestv i risk razvitiya nealkogol’noj zhirovoj bolezni pecheni [Tekst] / A. F. Sheptulina, Yu. A. Golubeva, O. M. Drapkina // Dokazatel’naya gastroenterologiya. – 2023. – T. 12, № 1. – S. 85–92.
22. STEPS: Rasprostranennost’ faktorov riska neinfekcionnyh zabolevanij v Respublike Belarus’, 2020 g. [Tekst]. – Kopengagen : Evropejskoe regional’noe byuro VOZ, 2022.
23. Pishcha radi pribyli. Kak pishchevoj kontinuum vredit zdorov’yu detej. Otchet o pitanii detej, 2025 g. [Tekst] : kratkoe izlozhenie otcheta / Detskij fond OON (YUNISEF). – N’yu-Jork : YUNISEF, 2025.
24. Bray, G. A. Fructose and risk of cardiometabolic disease [Tekst] / G. A. Bray // Curr. Atheroscler. Rep. – 2012. – Vol. 14. – P. 570–578. – DOI: 10.1007/s11883-012-0276-6.
25. Le, M. T. Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects [Tekst] / M. T. Le, R. F. Frye, C. J. Rivard et al. // Metabolism. – 2012. – Vol. 61, № 5. – P. 641–651. – DOI: 10.1016/j.metabol.2011.09.013.
26. Tran, C. Sex differences in lipid and glucose kinetics after ingestion of an acute oral fructose load [Tekst] / C. Tran, D. Jacot-Descombes, V. Lecoultre et al. // Br J Nutr. – 2010. – Vol. 104, № 8. – P. 1139–1147. – DOI: 10.1017/s000711451000190x.
27. Sievenpiper, J. L. Effect of fructose on body weight in controlled feeding trials: a systematic review and metaanalysis [Tekst] / J. L. Sievenpiper, R. J. de Souza, A. Mirrahimi et al. // Ann Intern Med. – 2012. – Vol. 156, № 4. – P. 291–304. – DOI: 10.7326/0003-4819-156-4-201202210-00007.
28. Ter Horst, K. W. Effect of fructose consumption on insulin sensitivity in nondiabetic subjects: A systematic review and meta-analysis of diet-intervention trials [Tekst] / K. W. Ter Horst, M. R. Schene, R. Holman et al. // American Journal of Clinical Nutrition. – 2016. – Vol. 104, № 6. – P. 1562–1576. – DOI: 10.3945/ajcn.116.137786.
29. Teff, K. L. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women [Tekst] / K. L. Teff, S. S. Elliott, M. Tschöp et al. // J Clin Endocrinol Metab. – 2004. – Vol. 89, № 6. – P. 2963–2972. – DOI: 10.1210/jc.2003-031855.
30. Shapiro, A. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding [Tekst] / A. Shapiro, W. Mu, C. Roncal et al. // Am J Physiol Regul Integr Comp Physiol. – 2008. – Vol. 295, № 5. – P. R1370-5. – DOI: 10.1152/ajpregu.00195.2008.
31. Stanhope, K. L. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/ obese humans [Tekst] / K. L. Stanhope, J. M. Schwarz, N. L. Keim et al. // J. Clin. Investig. – 2009. – Vol. 119. – P. 1322–1334. – DOI: 10.1172/JCI37385.
32. Vos, M. B. Dietary fructose in nonalcoholic fatty liver disease [Tekst] / M. B. Vos, J. E. Lavine // Hepatology. – 2013. – Vol. 57, № 6. – P. 2525–2531. – DOI: 10.1002/hep.26299.
33. Guideline: sugars intake for adults and children [Elektronnyj resurs] / World Health Organization. Rezhim dostupa: https://www.who.int/publications/i/item/9789241549028 (data obrashcheniya: 21.07.2020).
34. Laughlin, M. R. Normal roles for dietary fructose in carbohydrate metabolism [Tekst] / M. R. Laughlin // Nutrients. – 2014. – Vol. 6. – P. 3117–3129. – DOI: 10.3390/nu6083117.
35. Silivonchik, N. N. Nealkogol’naya zhirovaya bolezn’ pecheni: v fokuse fruktoza [Tekst] / N. N. Silivonchik, M. V. SHtonda // Gepatologiya i gastroenterologiya. – 2021. – T. 5, № 2. – S. 118–123. – DOI: 10.25298/2616-5546-2021-5-2-118-123.
36. DiStefano, J. K. Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis [Tekst] / J. K. DiStefano // Cellular and Molecular Life Sciences. – 2020. – Vol. 77, № 11. – P. 2079– 2090. – DOI: 10.1007/s00018-019-03390-0.
37. Schwarz, J. M. Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity [Tekst] / J. M. Schwarz, S. M. Noworolski, A. Erkin-Cakmak et al. // Gastroenterology. – 2017. – Vol. 153, № 3.– P. 743–752. – DOI: 10.1053/j.gastro.2017.05.043.
38. Ter Horst, K. W. Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease [Tekst] / K. W. Ter Horst, M. J. Serlie // Nutrients. – 2017. – Vol. 9, № 9. – P. 1–20. – DOI: 10.3390/nu9090981.
39. Tobey, T. A. Mechanism of insulin resistance in fructose-fed rats [Tekst] / T. A. Tobey, C. E. Mondon, I. Zavaroni, G. M. Reaven // Metabolism. – 1982. – Vol. 31. – P. 608– 612. – DOI: 10.1016/0026-0495(82)90100-7.
40. DiNicolantonio, J. J. Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity [Tekst] / J. J. DiNicolantonio, V. Mehta, N. Onkaramurthy, J. Okeefe // Prog. Cardiovasc. Dis. – 2017. – Vol. 61. – P. 3–9.
41. Baharuddin, B. The Impact of Fructose Consumption on Human Health: Effects on Obesity, Hyperglycemia, Diabetes, Uric Acid, and Oxidative Stress With a Focus on the Liver [Tekst] / B. Baharuddin // Cureus. – 2024. – Vol. 16, № 9. – Art. e70095. – DOI: 10.7759/cureus.70095.
42. Russo, E. Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age [Tekst] / E. Russo, G. Leoncini, P. Esposito et al. // Int. J. Mol. Sci. – 2020. – Vol. 21, № 12. – Art. 4479. – DOI: 10.3390/ijms21124479.
43. Georginova, O. A. Modificiruemye faktory pitaniya pri giperurikemii i podagre [Tekst] / O. A. Georginova, P. N. Astashkevich, T. N. Krasnova // Al’manah klinicheskoj mediciny. – 2022. – T. 50, № 4. – S. 264–273. – DOI: 10.18786/2072-0505-2022-50-028.
44. Ahadi, M. A review of non-alcoholic fatty liver disease in non-obese and lean individuals [Tekst] / M. Ahadi, K. Molooghi, N. Masoudifar et al. // Journal of Gastroenterology and Hepatology. – 2021. – Vol. 36, № 6. – P. 1497– 1507. – DOI: 10.1111/jgh.15353.
45. Kanerva, N. Fructose and sugar-sweetened beverage consumption and risk of developing chronic kidney disease: A prospective cohort study [Tekst] / N. Kanerva, S. Sandboge, N. E. Kaartinen, S. Männistö, J. G. Eriksson // Eur J Nutr. – 2024. – Vol. 63, № 5. – P. 1635–1646. – DOI: 10.1007/s00394-024-03368-0.
Review
For citations:
Nekhaichik T.A., Goduyko S.N., Bova A.A., Ermolkevich R.F., Kuntsevich D.M. Dismetabolic disorders in military personnel from the perspective of fruit-containing beverages consumption. Military Medicine. 2026;(2):129-138. (In Russ.) https://doi.org/10.51922/2074-5044.2026.2.129
JATS XML